Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.
Neuronal expression of the transcription factor serum response factor modulates myelination in a mouse multiple sclerosis model.
Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity.
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment.
[The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating?
Chronic inflammatory demyelinating polyneuropathy in children: a report of four patients with variable relapsing courses.
[Factors associated to the work situation of patients with multiple sclerosis].
A systematic review of factors associated with accidental falls in people with multiple sclerosis: a meta-analytic approach.
The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19: Reliability, Validity, and Factor Structure of the Persian Version.
Obstructive Sleep Apnea is an Under-Recognized and Consequential Morbidity in Multiple Sclerosis.
Patient perspectives on switching disease-modifying therapies in the NARCOMS registry.
Vitamin D deficiency and its role in neurological conditions: A review.
Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues.
High-intensity resistance training in multiple sclerosis - An exploratory study of effects on immune markers in blood and cerebrospinal fluid, and on mood, fatigue, health-related quality of life, muscle strength, walking and cognition.
HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.
Comparative effect of 25(OH)D3 and 1,25(OH)2D3 on Th17 cell differentiation.
Job retention interventions for persons with multiple sclerosis.
Longitudinal changes in quality of life and related psychosocial variables in australians with multiple sclerosis.
The brain as 'immunoprecipitator' of serum autoantibodies against NMDAR1.
Assessing intracortical myelin in the living human brain using myelinated cortical thickness.
Paced auditory serial addition test: National normative data.
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Prevalence of Multiple Sclerosis in the City of Volta Redonda - Rio De Janeiro, Brazil Using the Capture-Recapture Method.
Four Hours is Enough for Lactation Interruption After High-Dose Methylprednisolone Treatment in Multiple Sclerosis Mothers by Measuring Milk Cortisol Levels.
Pages
« first
‹ previous
…
630
631
632
633
634
635
636
637
638
…
next ›
last »